z-logo
Premium
Parkinson disease–associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 response
Author(s) -
Park Jeongho,
Lee JangWon,
Cooper Scott C.,
Broxmeyer Hal E.,
Can Jason R.,
Kim Chang H.
Publication year - 2017
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.1a0417-147rr
Subject(s) - myelopoiesis , biology , myeloid , lrrk2 , bone marrow , progenitor cell , immune system , immunology , haematopoiesis , cancer research , stem cell , microbiology and biotechnology , gene , mutation , genetics
The PD‐associated LRRK2 G2019S gene abnormally alters marrow myelopoiesis and peripheral myeloid cell differentiation, leading to decreased Th17 cell activity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here